Apr 27, 2020 / 12:30PM GMT
Operator
Greetings, and welcome to the Avadel Pharmaceuticals data call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to introduce your host, Tom McHugh, Chief Financial Officer. Please go ahead, sir.
Thomas S. McHugh - Avadel Pharmaceuticals plc - Senior VP & CFO
Good morning, and thank you for joining us on our conference call. On the call with me today are Greg Divis, Chief Executive Officer; and Dr. Jordan Dubow, Chief Medical Officer of Avadel. This morning, we should have released with top line data results from the Phase III REST-ON study. The release can be accessed on our website, www.avadel.com.
As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those
Avadel Pharmaceuticals PLC REST-ON Phase 3 Trial Data Call Transcript
Apr 27, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers